Pterostilbene inhibited advanced glycation end products (AGEs)-induced oxidative stress and inflammation by regulation of RAGE/MAPK/NF-κB in RAW264.7 cells

•Pterostilbene inhibited AGEs-induced oxidative stress.•Pterostilbene reduced AGEs-induced gene expression of inflammatory mediators.•Pterostilbene acted via RAGE/MAPK/NF-κB pathway.•Pterostilbene increased CD36 expression to remove local AGEs.